Evaxion Biotech AS (EVAX) showcases promising clinical advancements and strategic collaborations, while navigating financial hurdles and operational shifts.

Sinovac Biotech (SVA) announced that the company’s board of directors has decided to declare a special cash dividend of $55.00 per common ...

LENZ Therapeutics is progressing rapidly with its LNZ100 for presbyopia, aiming for a 2025 U.S. launch in a market valued at ...

Apollomics has tagged out of its partnership with TYG Oncology, terminating an immuno-oncology pact as part of a push to cut ...

Not only are biotech stocks subject to the boom-or-bust nature of their therapeutics, but they also operate in a cyclical ...

BioPharma Credit (LSE: BPCR) is one of the more esoteric investment trusts listed in London. Biotech is a specialist sector ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

1. Small-cap and midcap (smid-cap) biotech stocks recently traded at an enterprise-value to cash ratio of 1.2, according to biotech analyst Michael Yee at Jefferies. Historically, this group ...